NSE · Healthcare · Medical Care Facilities
EPS came in at 0.92 against a street estimate of 2.90 — a miss of 68.3%.
with an average price target of ₹816.00.
| Holder | Stake |
|---|---|
| Nippon Life India Trustee Ltd-a/c Nippon India Els | 5.88% |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund | 4.27% |
| Tata Mutual Fund - Tata Elss -tax Saver Fund | 4.13% |
| Franklin India Small Cap Fund | 1.57% |
| SBI Healthcare Opportunities Fund | 1.00% |
| Document | Date |
|---|---|
| Annual report FY2026 HEALTHCARE GLOBAL ENTERPRISES LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • 28th Annual General Meeting scheduled: Friday, September 18, 2026, at 5: | 2026-08-27 |
| Q1 FY27 earnings call HEALTHCARE GLOBAL ENTERPRISES LIMITED – Q1 FY27 SUMMARY --- HEADLINE NUMBERS • Revenue: INR 6,951 million (Q1 FY27), representing 13% year-on-year | 2026-08-10 |
| Quarterly results · Q1 FY27 HCG Q1 FY27 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹6,951 million in Q1 FY27, up 13% year-on-year from ₹6,132 million | 2026-08-06 |
| Investor presentation · Q1 FY27 HEALTHCARE GLOBAL ENTERPRISES LIMITED – Q1 FY2027 SUMMARY HEADLINE NUMBERS • Total Revenue: INR 6,951 Mn in Q1 FY27, up 13% year-on-year • Adjusted | 2026-08-06 |
| Q4 FY26 earnings call HEALTHCARE GLOBAL ENTERPRISES LIMITED - FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: INR 652 crore, up 11.3% year-on-year • FY26 Full Y | 2026-05-26 |
| Quarterly results · Q4 FY26 HEALTHCARE GLOBAL ENTERPRISES LIMITED – FY26 SUMMARY HEADLINE NUMBERS • Revenue from Operations (FY26): Rs. 25,454 million, up 15% year-on-year from | 2026-05-19 |
| Investor presentation HEALTHCARE GLOBAL ENTERPRISES LIMITED – FY26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • FY26 Revenue: INR 25,454 Mn, up 15% YoY (Q4FY26: INR 6, | 2026-05-19 |
| Q3 FY26 earnings call HEALTHCARE GLOBAL ENTERPRISES LIMITED Q3 & 9M FY26 EARNINGS SUMMARY --- HEADLINE NUMBERS • Q3 FY26 Revenue: INR 633 crore (13.4% YoY growth); Exclu | 2026-02-13 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Rights issue | 1 : 17 ex-date Mar 2, 2026 | 2026-03-02 |
| Announcement | Date |
|---|---|
| Step-down subsidiary agreed to acquire shares in an advanced molecular imaging company HealthCare Global Enterprises clarified a mismatch in its March 31, 2026 shareholding filing after questions from NSE. Certain promoter and promoter-group holdings appeared higher in the com | 2026-10-05 |
| Subsidiary acquires 26% equity stake in renewable energy company Healthcare Global Enterprises Limited (HCG), through its subsidiary HCG Manavata Oncology LLP, is acquiring a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited (EVRE) for | 2026-08-04 |
| Launch of new 132-bed comprehensive cancer hospital in Hebbal Healthcare Global Enterprises Limited (HGE) has announced the opening of a new comprehensive cancer hospital in Hebbal, Bengaluru, with a capacity of up to 132 beds. This facility will provi | 2026-05-19 |
| Completed acquisition of additional 34% stake in Vizag Hospital Healthcare Global Enterprises Limited has completed the acquisition of an additional 34% stake in Vizag Hospital and Cancer Research Centre Private Limited. This brings the company's total o | 2026-04-13 |
| Board approves investments in oncology subsidiary and additional stake acquisition Healthcare company approved investments totaling Rs. 253.66 crore across two oncology-focused ventures. First, Rs. 98 crore will be invested in HCG NCHRI Oncology LLP, a wholly-owned subsidi | 2026-03-30 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Healthcare Global Enterprises Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.